See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Amazon.com, Inc. (AMZN) - free report >>
Apple Inc. (AAPL) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Amazon.com, Inc. (AMZN) - free report >>
Apple Inc. (AAPL) - free report >>
Which Stocks are in the $1 Trillion Club?
The $1 Trillion Valuation Club is one of the most exclusive groups on Wall Street, and it just added its newest member: Alphabet Inc. (GOOGL - Free Report) . Google’s parent company is now the fourth publicly traded company worth $1 trillion.
iPhone maker Apple (AAPL - Free Report) became the first public company to pass the $1 trillion mark back in August 2018. E-commerce giant Amazon (AMZN - Free Report) was the second, but has since dropped below the trillion dollar level.
Other current members include Microsoft (MSFT - Free Report) and Saudi state oil giant Aramco, which recently went public; shares trade on Saudi Arabia’s Tadawul stock exchange. Social media behemoth Facebook could become the next trillion-dollar public company; its current valuation sits at roughly $630 billion
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>